{"id":3589,"date":"2023-06-15T23:08:44","date_gmt":"2023-06-15T21:08:44","guid":{"rendered":"http:\/\/www.internalmed-journal.in.ua\/?p=3589"},"modified":"2023-08-11T14:21:00","modified_gmt":"2023-08-11T12:21:00","slug":"%d1%85%d1%80%d0%be%d0%bd%d1%96%d1%87%d0%bd%d0%b0-%d1%81%d0%b5%d1%80%d1%86%d0%b5%d0%b2%d0%b0-%d0%bd%d0%b5%d0%b4%d0%be%d1%81%d1%82%d0%b0%d1%82%d0%bd%d1%96%d1%81%d1%82%d1%8c-%d1%82%d0%b0-%d0%be%d1%81","status":"publish","type":"post","link":"http:\/\/www.internalmed-journal.in.ua\/en\/archives\/3589","title":{"rendered":"Chronic heart failure and osteoporosis: etiological and clinicalpathogenetic relationships"},"content":{"rendered":"

Prof<\/strong>. <\/strong>Korzh<\/strong> O<\/strong>.<\/strong>M<\/strong>., <\/strong>PHD<\/strong> Korzh<\/strong> I<\/strong>.<\/strong>V<\/strong>.<\/strong><\/p>\n

Kharkiv National Medical University <\/strong><\/p>\n

Sytenko Institute of Spine and Joint Pathology of National Academy of Medical Sciences of Ukraine <\/strong><\/p>\n

Current epidemiological and clinical data confirm the relationship between chronic heart failure (CHF) and osteoporosis (OP), which cannot be explained only by aging and the use of pharmacological drugs. Clinical and epidemiological studies show that CHF is most often accompanied by low bone mineral density, a high risk of fractures and, moreover, a fourfold increase in the risk of any fracture requiring hospitalization. Further research on the relationship between CHF and OP is needed, as understanding the common mechanisms of disease development will serve as a platform for preventive and therapeutic interventions aimed at both conditions.<\/p>\n

Key words:<\/strong> chronic heart failure, osteoporosis, bone mineral density, bone metabolism.<\/p>\n

\u00a0<\/strong>https:\/\/doi.org\/10.15407\/internalmed2023.02.084<\/strong><\/a><\/p>\n

Download.PDF (ukr)<\/strong><\/a><\/p>\n

Cite:<\/strong><\/p>\n

    \n
  1. \u041a\u043e\u0440\u0436, \u041e.\u041c. \u0425\u0440\u043e\u043d\u0456\u0447\u043d\u0430 \u0441\u0435\u0440\u0446\u0435\u0432\u0430 \u043d\u0435\u0434\u043e\u0441\u0442\u0430\u0442\u043d\u0456\u0441\u0442\u044c \u0442\u0430 \u043e\u0441\u0442\u0435\u043e\u043f\u043e\u0440\u043e\u0437: \u0435\u0442\u0456\u043e\u043b\u043e\u0433\u0456\u0447\u043d\u0456 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u043a\u043e\u043f\u0430\u0442\u043e\u0433\u0435\u043d\u0435\u0442\u0438\u0447\u043d\u0456 \u0432\u0437\u0430\u0454\u043c\u043e\u0437\u0432\u2019\u044f\u0437\u043a\u0438 \/ \u041e.\u041c. \u041a\u043e\u0440\u0436, \u0406.\u0412. \u041a\u043e\u0440\u0436 \/\/ \u0421\u0445\u0456\u0434\u043d\u043e\u0454\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b \u0432\u043d\u0443\u0442\u0440\u0456\u0448\u043d\u044c\u043e\u0457 \u0442\u0430 \u0441\u0456\u043c\u0435\u0439\u043d\u043e\u0457 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0438. – 2023. – \u2116 2. – \u0421. 84-89. http:\/\/doi.org\/10.15407\/internalmed2023.02.084<\/li>\n
  2. Korzh OM, Korzh IV. [Chronic heart failure and osteoporosis: etiological and clinicalpathogenetic relationships]. Shidnoevr. z. vnutr. simejnoi med. 2023;2:84-89. Ukrainian. http:\/\/doi.org\/10.15407\/internalmed2023.02.084<\/li>\n<\/ol>\n

    References:<\/strong><\/p>\n

      \n
    1. Groenewegen A, Rutten FH, Mosterd A. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56. doi:10.1002\/ ejhf.1858.<\/li>\n
    2. Virani SS, Alonso A, Benjamin E, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee et al. Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics -2020 update: A report from the American Heart Association. Circulation. 2020;141:e139\u2013596. doi: 10.1161\/CIR.0000000000000757.<\/li>\n
    3. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-59. doi:10.1016\/S0140- 6736(17)32154-2.<\/li>\n
    4. Camacho PM, Petak SM, Binkley N. American association of clinical endocrinologists\/American college of endocrinology. Clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis \u2014 2020. Endocr Pract. 2020;26(Suppl 1):1-46. doi:10.4158\/GL-2020- 0524SUPPL.<\/li>\n
    5. Sauer AJ, Bhardw AJ, Srivastava AV. On leadership-a call to action for aspirational leadership development for programs supporting patients with heart failure. J Card Fail. 2021;27(9):1017\u20131019. doi: 10.1016\/j.cardfail.2021.05.021.<\/li>\n
    6. Ahmadieh H, Arabi A. Association between vitamin D and cardiovascular health: Myth or Fact? A narrative review of the evidence. Womens Health (Lond). 2023;19:17455057231158222. doi:10.1177\/17455057231158222.<\/li>\n
    7. Latic N, Erben RG. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure. Int J Mol Sci. 2020;21(18):6483. Published 2020 Sep 4. doi:10.3390\/ijms21186483<\/li>\n
    8. Notarnicola A, Maccagnano G, Moretti L. Cardiopathy and osteoporosis: the epidemiology in a region of Italy. J Biol Regul Homeost Agents. 2017;31(1):251-5.<\/li>\n
    9. Xing W, Lv X, Gao W. Bone mineral density in patients with chronic heart failure: a meta-analysis. Clin Interv Aging. 2018;13:343-53. doi:10.2147\/CIA.S154356.<\/li>\n
    10. Majumdar SR, Ezekowitz JA, Lix LM. Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects. J Clin Endocrinol Metab. 2012;97(4):1179-86. doi:10.1210\/jc.2011-3055.<\/li>\n
    11. Ge G, Li J, Wang Q. Heart failure and fracture risk: a metaanalysis.Osteoporos Int. 2019;30(10):1903-9. doi:10.1007\/ s00198-019-05042-2.<\/li>\n
    12. Loncar G, Garfias-Veitl T, Valentova M. Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure [published online ahead of print, 2023 Feb 13]. Eur J Heart Fail. 2023;10.1002\/ ejhf.2794. doi:10.1002\/ejhf.2794.<\/li>\n
    13. van Diepen S, Majumdar SR, Bakal JA. Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation. 2008;118(19):1946-52. doi:10.1161.108.784009.<\/li>\n
    14. Carbone L, Buzkova P, Fink HA. Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J. 2010;31:77-84. doi:10.1093\/eurheartj\/ehp483.<\/li>\n
    15. Pfister R, Michels G, Sharp SJ. Low bone mineral density predicts incident heart failure in men and women: the EPIC (European Prospective Investigation into Cancer and Nutrition) \u2014 Norfolk prospective study. JACC Heart Fail. 2014;2(4):380-9. doi:10.1016\/j.jchf.2014.03.010.<\/li>\n
    16. Fohtung RB, Brown DL, Koh WJ. Bone Mineral Density and Risk of Heart Failure in Older Adults: The Cardiovascular Health Study. J Am Heart Assoc. 2017;13;6(3):e004344. doi:10.1161\/JAHA.116.004344.<\/li>\n
    17. Loncar G, Cvetinovic N, Lainscak M. Bone in heart failure. J Cachexia Sarcopenia Muscle. 2020;11(2):381-93. doi:10.1002\/jcsm.12516.<\/li>\n
    18. Fohtung RB, Brown DL, Koh WJ. Bone Mineral Density and Risk of Heart Failure in Older Adults: The Cardiovascular Health Study. J Am Heart Assoc. 2017;6(3):e004344. Published 2017 Mar 13. doi:10.1161\/JAHA.116.004344.<\/li>\n
    19. Saponaro F, Saba A, Frascarelli S. Vitamin D measurement and effect on outcome in a cohort of patients with heart failure. Endocr Connect. 2018;7(9):957-64. doi:10.1530\/EC-18-0207.<\/li>\n
    20. Bhatta L, Cepelis A, Vikjord SA. Bone mineral density and risk of cardiovascular disease in men and women: the HUNT study. Eur J Epidemiol. 2021;36(11):1169-1177. doi:10.1007\/ s10654-021-00803-y.<\/li>\n
    21. Roffe-Vazquez DN, Huerta-Delgado AS, Castillo EC. Correlation of vitamin D with inflammatory cytokines, atherosclerotic parameters, and lifestyle factors in the setting of heart failure: a 12-month follow-up study. Int J Mol Sci. 2019;20(22): 5811. doi:10.3390\/ijms20225811.<\/li>\n
    22. Wu GY, Wu T, Xu BD. Effect of parathyroid hormone on cardiac function in rats with cardiomyopathy. Exp Ther Med. 2018;16(4):2859-66. doi:10.3892\/etm.2018.6528.<\/li>\n
    23. Vadana M, Cecoltan S, Ciortan L. Parathyroid Hormone Induces Human Valvular Endothelial Cells Dysfunction That Impacts the Osteogenic Phenotype of Valvular Interstitial Cells. Int J Mol Sci. 2022;23(7):3776. Published 2022 Mar 29. doi:10.3390\/ijms23073776.<\/li>\n
    24. Loncar G, Bozic B, Cvetinovic N. Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure. J Endocrinol Invest. 2017;40(3): 297-304. doi:10.1007\/s40618-016-0561-2.<\/li>\n
    25. Klein GL. Is calcium a link between inflammatory bone resorption and heart disease?. Elife. 2022;11:e83841. doi:10.7554\/eLife.83841.<\/li>\n
    26. Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circulation Research. 2020;126:1260\u20131280. doi: 10.1161\/ CIRCRESAHA.120.315937.<\/li>\n
    27. Campos-Obando N, Kavousi M, Roeters van Lennep JE, Rivadeneira F, Hofman A, Uitterlinden AG, Franco OH, Zillikens MC. Bone health and coronary artery calcification: the Rotterdam study. Atherosclerosis. 2015;241:278\u2013283. doi: 10.1016\/j.atherosclerosis.2015.02.013.<\/li>\n
    28. Canaff L, Zhou X, Hendy GN. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1\/3 and Sp1\/3. The Journal of Biological Chemistry. 2008;283:13586\u201313600. doi: 10.1074\/jbc. M708087200.<\/li>\n
    29. Nakamura Y, Nakano M, Suzuki T. Two adipocytokines, leptin and adiponectin, independently predict osteoporotic fracture risk at different bone sites in postmenopausal women. 2020;(137):115404. doi:10.1016\/j.bone.2020.115404.<\/li>\n
    30. Poetsch MS, Strano A, Guan K. Role of Leptin in Cardiovascular Diseases. Front Endocrinol. 2020;11:354. doi:10.3389\/fendo. 2020.00354.<\/li>\n
    31. Bozic B, Loncar G, Prodanovic N. Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure. J Card Fail. 2010;16(4):301-7. doi:10.1016\/j.cardfail.2009.12.015.<\/li>\n
    32. Tsutamoto T, Tanaka T, Sakai H. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J. 2007;28:1723-30. doi:10.1093\/eurheartj\/ehm154.<\/li>\n
    33. Tanna N, Patel K, Moore AE, Dulnoan D, Edwards S, Hampson G. The relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial calcification and stiffness: a cross-sectional study in postmenopausal women. J Endocrinol Invest. 2017;40(12):1345- 1353. doi:10.1007\/s40618-017-0711-1<\/li>\n
    34. Elefteriou F, Ahn JD, Takeda S. Leptin regulation of bone resorption by the sympathetic nervous system and CART. 2005;434(7032):514-20. doi:10.1038\/nature03398.<\/li>\n
    35. Ueland T, Yndestad A, Oie E. Dysregulated osteoprotegerin\/RANK ligand\/RANK axis in clinical and experimental heart failure. 2005;111(9):2461-8. doi:10.1161\/01.CIR.0000165119.62099.14.<\/li>\n
    36. Leistner DM, Seeger FH, Fischer A. Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. Circ Heart Fail. 2012;5(6):769-77. doi:10.1161\/ CIRCHEARTFAILURE.111.966093.<\/li>\n
    37. Farhat GN, Cauley JA. The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab. 2008;5(1): 19-34.<\/li>\n
    38. Gaudio A, Xourafa A, Rapisarda R. Peripheral artery disease and osteoporosis: Not only agerelated. Mol Med Rep. 2018;18(6):4787-92. doi:10.3892\/mmr.2018.9512.<\/li>\n
    39. Katano S, Yano T, Tsukada T. Clinical determinants and prognostic impact of osteoporosis in patients with chronic heart failure. Eur Heart J. 2020;41(2):3418. doi:10.1093\/ehjci\/ ehaa946.3418.<\/li>\n
    40. Aluoch AO, Jessee R, Habal H. Heart failure as a risk factor for osteoporosis and fractures. Curr Osteoporos Rep. 2012;10(4):258-69. doi:10.1007\/s11914-012-0115-2.<\/li>\n
    41. Gage BF, Birman-Deych E, Radford MJ. Risk of Osteoporotic Fracture in Elderly Patients Taking Warfarin: Results from the National Registry of Atrial Fibrillation 2. Arch Intern Med. 2006;166(2):241-6. doi:10.1001\/ archinte.166.2.241<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

      Prof. Korzh O.M., PHD Korzh I.V. Kharkiv National Medical University Sytenko Institute of Spine and Joint Pathology of National Academy of Medical Sciences of Ukraine Current epidemiological and clinical data confirm the relationship between chronic heart failure (CHF) and osteoporosis (OP), which cannot be explained only by aging and the use of pharmacological drugs. Clinical…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58,9,10,108,117,106],"tags":[],"translation":{"provider":"WPGlobus","version":"2.12.2","language":"en","enabled_languages":["uk","en","ru"],"languages":{"uk":{"title":true,"content":true,"excerpt":false},"en":{"title":true,"content":true,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false}}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3589"}],"collection":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/comments?post=3589"}],"version-history":[{"count":6,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3589\/revisions"}],"predecessor-version":[{"id":3747,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3589\/revisions\/3747"}],"wp:attachment":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/media?parent=3589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/categories?post=3589"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/tags?post=3589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}